Close menu




March 2nd, 2026 | 08:00 CET

Feeding a Growing World: Bayer, K+S, and MustGrow Biologics! Mustard, as a biological innovation, is transforming the agriculture of tomorrow!

  • agritech
  • mustard
  • biologics
  • fertilizer
Photo credits: pixabay

Global agriculture faces mounting structural pressure. More than 8 billion people live on Earth today, and every person needs food every day. But the fields where we can grow food are getting smaller. Traditional methods of agriculture are losing acceptance, as synthetic fertilizers and chemical crop protection agents face stricter environmental oversight worldwide. That is why companies such as MustGrow Biologics, Bayer, and K+S are becoming increasingly important. These companies are working on a new type of agriculture. They are attempting to strike a balance: they aim to ensure good harvests while also protecting nature. The smaller innovator, MustGrow Biologics, exemplifies the shift toward effective biological alternatives in modern agriculture.

time to read: 4 minutes | Author: Mario Hose
ISIN: MUSTGROW BIOLOGICS CORP. | CA62822A1030 , K+S AG NA O.N. | DE000KSAG888 , BAYER AG NA O.N. | DE000BAY0017

Table of contents:


    The world needs higher yields: How Bayer and K+S contribute

    Global food demand continues to rise, while available arable land remains limited. As a result, agricultural productivity per hectare must increase sustainably. Companies such as Bayer and K+S play a central role in this equation. K+S has long been supplying essential minerals for agriculture for many years. Without these fertilizers, the soil would deteriorate and harvests volumes would decline sharply. Bayer, meanwhile, supports farmers through advanced seed technologies and crop protection solutions designed to safeguard yields against pests and disease pressure.

    However, both companies are facing major changes. Consumers are demanding not only a sufficient food supply, but also higher standards for health and environmental protection. Chemical residues in the soil or drinking water are frowned upon and no longer accepted. Authorities around the world are banning more and more chemical agents. This creates a major challenge for farmers. They need new agents that work just as well as the old chemicals but do not harm the environment. This is precisely where a large new market is emerging. Bayer is therefore actively seeking more environmentally friendly solutions. Natural or biologically derived inputs that enhance plant growth and combat pests are in high demand today. Agriculture is undergoing a major structural transformation, with conventional methods giving way to new ideas and possibilities.

    The mustard pioneer: MustGrow Biologics revolutionizes agriculture

    Amidst this exciting upheaval, one name stands out: MustGrow Biologics. However, this company is not a "typical" agricultural business, but rather a visionary that makes use of one of the oldest crops in the world: mustard. Have you ever wondered why mustard has such a natural pungency? It is the plant's defense mechanism. MustGrow has managed to extract these natural defense molecules and transform them into a highly effective technology platform. It is impressive to see how modern science and the power of nature come together here. The company now has around 110 patents granted and pending for this technology. This enhances technological defensibility and may contribute to the development of a sustainable competitive moat, provided commercial execution keeps pace.

    MustGrow's technology addresses the areas where farmers suffer the most. Take the TerraMG product, for example. It is a biological soil pesticide derived directly from mustard. It combats diseases and pests in the soil before they can even damage the plant. This is particularly exciting for rapeseed, one of Canada's most important crops. There is a disease called clubroot, for which there have been few effective remedies to date. In two-year field trials, TerraMG has shown what it can do. The results are nothing short of sensational. In wet conditions, clubroot spores were reduced by up to 95%. For farmers, this means a significant increase in yield, which translates into hard cash. But at the same time, it also means healthier plants and more stable, predictable harvests.

    But MustGrow can do more than just protect. With TerraSante, they have developed a biofertilizer product that literally revives the soil. It provides proteins and carbohydrates from mustard seeds, which serve as food for beneficial microorganisms in the soil. Healthy soil retains water better and delivers nutrients to the roots more efficiently. In the US, TerraSante is already registered in states such as California and is even certified for organic farming.

    MustGrow has recently improved its financial position and raised fresh capital through a private placement of USD 2 million. This money will be invested directly in production and distribution.

    Alliances for the future

    It is no coincidence that a heavyweight like Bayer is seeking proximity to MustGrow Biologics. In December 2023, the two companies signed a groundbreaking commercial license agreement. Bayer will market MustGrow's biocontrol technologies in Europe, the Middle East, and Africa.

    When a global market leader such as Bayer enters into a commercial agreement with MustGrow, it provides external validation of the underlying technology. Something big could be in the making here, and this cooperation demonstrates how the major players in industry are increasingly integrating innovation to expand their portfolios. Fresh ideas and the flexibility of small, young companies are needed to help meet the demands of a growing world population.

    Cooperation between these different companies could perhaps lead to great success. While K+S continues to provide the mineral basis for fertile soils, Bayer contributes the global infrastructure and MustGrow the "biological secret weapon, mustard."

    Together, they form a chain that ranges from soil improvement to the protection of the finished harvest. The goal is clear: obtaining higher harvest yields in the most sustainable way possible. World hunger is growing. Solutions must be found that work today and leave behind a healthy environment tomorrow. MustGrow also demonstrates with its products for post-harvest treatment, for example, for potatoes, that it has the entire life cycle of a plant in mind. Even the formation of sprouts in stored potatoes can be suppressed naturally using its technology. This reduces food waste and secures supply.


    Three stocks for a greener and more productive world. Bayer is an experienced giant that is courageously embracing change and securing its future through partnerships. Then there is K+S, which, as a fertilizer specialist, is likely to remain indispensable for the basic supply of global agriculture. And MustGrow Biologics. This company is innovative and uses nature to solve problems that chemistry has failed to address. MustGrow is a beacon of hope and is already delivering tangible results in the fields of Canada and the US. With a strong patent base, fresh capital, and a world-class partner like Bayer at its side, MustGrow could be on a steep upward trajectory. Very exciting!


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") currently hold or hold shares or other financial instruments of the aforementioned companies and speculate on their price developments. In this respect, they intend to sell or acquire shares or other financial instruments of the companies (hereinafter each referred to as a "Transaction"). Transactions may thereby influence the respective price of the shares or other financial instruments of the Company.
    In this respect, there is a concrete conflict of interest in the reporting on the companies.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
    For this reason, there is also a concrete conflict of interest.
    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author



    Related comments:

    Commented by Armin Schulz on February 24th, 2026 | 07:15 CET

    MustGrow Biologics and its partnership with Bayer: Why the stock is only just getting started

    • Agriculture
    • Sustainability
    • biologics
    • agritech

    Global agriculture is facing a paradox. It needs to feed more people, but with fewer chemical inputs. Worldwide, 460 pesticides are now banned or restricted across 162 countries. The era of synthetic active ingredients is coming to an end – but what comes next? A Canadian company believes it has found the answer. It grows in the field, is spicy and yellow: mustard. MustGrow Biologics has developed a technology that uses the natural defenses of the mustard plant to remediate soils and increase yields. What sounds like a niche idea could turn out to be one of the most exciting investments in the agricultural sector.

    Read

    Commented by Nico Popp on February 20th, 2026 | 07:25 CET

    Agricultural revolution breaks the billion-dollar barrier: Why MustGrow Biologics, Bayer, and Bioceres Crop Solutions are ending the era of chemicals

    • biologics
    • Agriculture
    • agritech
    • Sustainability
    • Investments

    The agricultural industry is currently transitioning from toxic chemicals to high-performance biologics. In this market environment, various players are positioning themselves with complementary strategies to capture the gigantic market for sustainable crop protection, which is expected to generate billions of dollars in revenue in the future. The ongoing deterioration of farmland and increasingly restrictive regulations are forcing farmers and corporations alike to rethink their approaches. It is no longer just about purely ecological ideals, but about food for humanity. Established agricultural giants and innovative technology companies are working feverishly to secure yields without further depleting nature. In this race, clear winners are emerging who are laying the foundation for the agriculture of the future and offering investors unprecedented opportunities. MustGrow Biologics is an exciting candidate.

    Read

    Commented by Fabian Lorenz on February 9th, 2026 | 07:30 CET

    Bayer shares in the fast lane! Partner MustGrow Biologics facing revaluation!

    • Agritech
    • Sustainability
    • fertilizer
    • Agriculture

    For Bayer, things are currently going extremely well. The group is bringing its problem areas under control while reporting tangible progress in its pharmaceutical business. In the shadow of this, the company has secured the license for a new biologically safe product platform for fertilizers. Its partner in this venture is MustGrow Biologics. The company is on the verge of transitioning from research to commercialization, with management planning a market launch later this year. Production capacities are already being expanded in Asia. Against this backdrop, MustGrow shares appear poised for a revaluation - and the company is increasingly emerging as a potential takeover candidate.

    Read